Cargando…
Targeting MMP-9 in Diabetic Foot Ulcers
Diabetic foot ulcers (DFUs) are significant complications of diabetes and an unmet medical need. Matrix metalloproteinases (MMPs) play important roles in the pathology of wounds and in the wound healing process. However, because of the challenge in distinguishing active MMPs from the two catalytical...
Autores principales: | Jones, Jeffrey I., Nguyen, Trung T., Peng, Zhihong, Chang, Mayland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630664/ https://www.ncbi.nlm.nih.gov/pubmed/31121851 http://dx.doi.org/10.3390/ph12020079 |
Ejemplares similares
-
Editorial: Pathogenesis of diabetic foot ulcers
por: Peng, Zhihong, et al.
Publicado: (2023) -
A Review: Matrix Metallopeptidase-9 Nanoparticles Targeted for the Treatment of Diabetic Foot Ulcers
por: Jifar, Wakuma Wakene, et al.
Publicado: (2021) -
MMP-9 inhibitors impair learning in spontaneously hypertensive rats
por: Raz, Limor, et al.
Publicado: (2018) -
Adiponectin as a therapeutic target for diabetic foot ulcer
por: Abdalla, Mona Mohamed Ibrahim, et al.
Publicado: (2023) -
Management of Diabetic Foot Ulcers
por: Alexiadou, Kleopatra, et al.
Publicado: (2012)